PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsCellulitis
MeSH D002481 - cellulitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012874:Infectious skin diseases
$
Success rate
D013492:Suppuration
0 Companies
0 Drugs
Success rate
D003240:Connective tissue diseases
0 Companies
0 Drugs
Success rate
D002481: 
Cellulitis
$
Success rate
D008158:Ludwig's angina
0 Companies
0 Drugs
Success rate
D054517:Orbital cellulitis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCloxacillin Cloxacillin  1982-01-01   
Oxacillin Oxacillin  1982-01-01   
GSKOxacillin Bactocill  1982-01-01   
Cloxacillin Cloxapen  1982-01-01   
Nafcillin Nallpen  1982-01-01   
SandozNafcillin Nafcillin  1984-08-02   
Oxacillin Oxacillin  1982-01-01   
WyethNafcillin Unipen  1986-12-16   
HospiraOxacillin Oxacillin  2015-12-11   
WockhardtOxacillin Oxacillin  2017-07-31   
Bristol Myers SquibbCloxacillin Cloxacillin  1982-01-01   
Nafcillin Nafcillin  1982-01-01   
Oxacillin Oxacillin  1982-01-01   
Oxacillin Prostaphlin  1982-01-01   
Cloxacillin Tegopen  1982-01-01   
ANI PharmaceuticalsOxacillin Oxacillin  1982-01-01   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
58%
7/12
Phase 3
30%
6/20
Approved: 5Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Gilead Sciences
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use